BACKGROUND AND PURPOSE: Making a limb transiently ischemic has been shown to induce ischemic tolerance in a distant organ. This phenomenon is known as remote ischemic limb preconditioning. We conducted a Phase IB study of remote ischemic limb preconditioning to determine the safety and feasibility of increasing durations of limb ischemia in patients with subarachnoid hemorrhage. METHODS: Patients with aneurysmal subarachnoid hemorrhage underwent limb preconditioning every 24 to 48 hours for 14 days. Limb preconditioning consisted of 3 5-minute inflations of a blood pressure cuff to 200 mm Hg around a limb followed by 5 minutes of reperfusion. In the lead-in phase, we preconditioned the upper extremities, but this proved impractical and we began preconditioning the leg in a similar manner. Ischemia times were then escalated to 7.5 and 10 minutes. After each session, a visual analog scale was obtained and the extremity examined for neurovascular complications. RESULTS: A total of 33 patients completed the study. Mean age was 53±12 years and mean Hunt Hess score was 2.4±0.9. In the lead-in phase, an average of 7.7±2.4 preconditioning sessions was completed with mean visual analog scale 3.6±3.4. In the dose escalation phase, an average of 8.6±2.1 preconditioning sessions was done with mean visual analog scale 1.8±2.2 and 2.5±2.9 for the 7.5- and 10-minute cohorts, respectively. No session was prematurely terminated due to subject discomfort. No objective signs of neurovascular injury were observed. CONCLUSIONS: We found limb preconditioning to be safe and well tolerated, even at ischemia times of 10 minutes, in critically ill patients with subarachnoid hemorrhage.
BACKGROUND AND PURPOSE: Making a limb transiently ischemic has been shown to induce ischemic tolerance in a distant organ. This phenomenon is known as remote ischemic limb preconditioning. We conducted a Phase IB study of remote ischemic limb preconditioning to determine the safety and feasibility of increasing durations of limb ischemia in patients with subarachnoid hemorrhage. METHODS:Patients with aneurysmal subarachnoid hemorrhage underwent limb preconditioning every 24 to 48 hours for 14 days. Limb preconditioning consisted of 3 5-minute inflations of a blood pressure cuff to 200 mm Hg around a limb followed by 5 minutes of reperfusion. In the lead-in phase, we preconditioned the upper extremities, but this proved impractical and we began preconditioning the leg in a similar manner. Ischemia times were then escalated to 7.5 and 10 minutes. After each session, a visual analog scale was obtained and the extremity examined for neurovascular complications. RESULTS: A total of 33 patients completed the study. Mean age was 53±12 years and mean Hunt Hess score was 2.4±0.9. In the lead-in phase, an average of 7.7±2.4 preconditioning sessions was completed with mean visual analog scale 3.6±3.4. In the dose escalation phase, an average of 8.6±2.1 preconditioning sessions was done with mean visual analog scale 1.8±2.2 and 2.5±2.9 for the 7.5- and 10-minute cohorts, respectively. No session was prematurely terminated due to subject discomfort. No objective signs of neurovascular injury were observed. CONCLUSIONS: We found limb preconditioning to be safe and well tolerated, even at ischemia times of 10 minutes, in critically illpatients with subarachnoid hemorrhage.
Authors: Michael M H Cheung; Rajesh K Kharbanda; Igor E Konstantinov; Mikiko Shimizu; Helena Frndova; Jia Li; Helen M Holtby; Peter N Cox; Jeffrey F Smallhorn; Glen S Van Arsdell; Andrew N Redington Journal: J Am Coll Cardiol Date: 2006-05-15 Impact factor: 24.094
Authors: Stewart R Walsh; S A Nouraei; Tjun Y Tang; Umar Sadat; Roger H Carpenter; Michael E Gaunt Journal: Vasc Endovascular Surg Date: 2010-05-18 Impact factor: 1.089
Authors: Ishtiaq A Rahman; Jorge G Mascaro; Rick P Steeds; Michael P Frenneaux; Peter Nightingale; Peter Gosling; Peter Townsend; John N Townend; David Green; Robert S Bonser Journal: Circulation Date: 2010-09-14 Impact factor: 29.690
Authors: Derek J Hausenloy; Peter K Mwamure; Vinod Venugopal; Joanne Harris; Matthew Barnard; Ernie Grundy; Elizabeth Ashley; Sanjeev Vichare; Carmelo Di Salvo; Shyam Kolvekar; Martin Hayward; Bruce Keogh; Raymond J MacAllister; Derek M Yellon Journal: Lancet Date: 2007-08-18 Impact factor: 79.321
Authors: Ziad A Ali; Chris J Callaghan; Eric Lim; Ayyaz A Ali; S A Reza Nouraei; Asim M Akthar; Jonathan R Boyle; Kevin Varty; Rajesh K Kharbanda; David P Dutka; Michael E Gaunt Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang Journal: Exp Neurol Date: 2015-04-18 Impact factor: 5.330
Authors: Arzu Bilgin-Freiert; Joshua R Dusick; Nathan R Stein; Maria Etchepare; Paul Vespa; Nestor R Gonzalez Journal: Transl Stroke Res Date: 2012-04-10 Impact factor: 6.829